Abstract
Neoadjuvant treatment is increasingly being used in patients with breast cancer. Understanding the effects of neoadjuvant agents in the perioperative setting is crucial as it can affect morbidity. Understanding how these agents should be used to maximize optimal time to surgery is crucial as delays can negatively affective cancer outcomes. This review aims to discuss the perioperative considerations surgeons should be aware of prior to scheduling surgery for patients receiving chemotherapy, endocrine therapy, chemotherapy, targeted therapy, and immunotherapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 401-405 |
| Number of pages | 5 |
| Journal | Clinical Breast Cancer |
| Volume | 25 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jul 2025 |
Keywords
- Neoadjuvant therapy
- Perioperative
- Surgery
- Systemic therapy
- Time to surgery
ASJC Scopus subject areas
- Oncology
- Cancer Research
Divisions
- Surgical Oncology
Fingerprint
Dive into the research topics of 'Perioperative Considerations of Breast Cancer Neoadjuvant Treatments'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS